Articles |
From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Epidemiology Unit, IRCCS Maggiore Hospital and Geriatric Unit, Institute of Internal Medicine, University of Milano (P.M.M., D.M., G.M., F.P., L.T., E.S., E.T.); the Institute of Clinical Medicine, University of Parma (P.S.); the Department of Internal Medicine, University of Genoa (S.B.); and the Department of Biochemical Sciences, University of Modena (C.F.), Italy.
Correspondence to Dr P.M. Mannucci, via Pace 9, 20122 Milano, Italy. E-mail pmm_isth{at}energy.it
Abstract Gene polymorphisms associated with the plasma levels of fibrinogen, factor VII, and plasminogen activator inhibitor 1 (PAI-1)hemostasis proteins that help to predict the risk of atherothrombotic diseasewere compared in 124 healthy individuals
100 years old and 130 young, healthy individuals to identify genetic influences on extreme longevity. We investigated the restriction fragment length polymorphism G/A-455 located in the promoter of the ß-fibrinogen gene, the guanine insertion/deletion polymorphism 4G/5G in the promoter of the PAI-1 gene, and the R353Q substitution polymorphism in exon 8 of the factor VII gene. Alleles and genotypes associated with elevated plasma levels of fibrinogen and factor VII were found with similar frequencies in centenarians and in the comparison group. However, in centenarians there was a significantly higher frequency of the 4G allele and of the homozygous 4G4G genotype associated with high PAI-1 levels. Since high PAI-1 is considered a predictor of recurrent myocardial infarction in young men, it is intriguing that the corresponding genetic marker is more frequent in centenarians who have escaped major age-related atherothrombotic disease and reached the extreme limits of human life. Homozygosity for the 4G allele, despite its association with impaired fibrinolysis, is compatible with successful aging.
Key Words: centenarians fibrinogen factor VII plasminogen activator inhibitor 1 gene polymorphisms
This article has been cited by other articles:
![]() |
M. D. Fallin and A. Matteini Genetic Epidemiology in Aging Research J Gerontol A Biol Sci Med Sci, January 23, 2009; (2009) gln021v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kimura, M. Barbieri, J. P. Gardner, J. Skurnick, X. Cao, N. van Riel, M. R. Rizzo, G. Paoliso, and A. Aviv Leukocytes of exceptionally old persons display ultra-short telomeres Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2210 - R2217. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Benedictis and C. Franceschi The Unusual Genetics of Human Longevity Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): pe20 - pe20. [Abstract] [Full Text] |
||||
![]() |
H. R. Warner The Future of Aging Interventions: Current Status of Efforts to Measure and Modulate the Biological Rate of Aging J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B692 - B696. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Brown, L. J. Murphey, N. Srikuma, N. Koschachuhanan, G. H. Williams, and D. E. Vaughan Interactive Effect of PAI-1 4G/5G Genotype and Salt Intake on PAI-1 Antigen Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 1071 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Barzilai and A. R. Shuldiner Searching for Human Longevity Genes: The Future History of Gerontology in the Post-genomic Era J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 83M - 87. [Abstract] [Full Text] |
||||
![]() |
M. Roest, Y. T. van der Schouw, J. D. Banga, M. J. Tempelman, P. G. de Groot, J. J. Sixma, and D. E. Grobbee Plasminogen Activator Inhibitor 4G Polymorphism Is Associated With Decreased Risk of Cerebrovascular Mortality in Older Women Circulation, January 4, 2000; 101(1): 67 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nauck, H. Wieland, and W. Marz Rapid, Homogeneous Genotyping of the 4G/5G Polymorphism in the Promoter Region of the PAI1 Gene by Fluorescence Resonance Energy Transfer and Probe Melting Curves Clin. Chem., August 1, 1999; 45(8): 1141 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cesari and G. P. Rossi Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1378 - 1386. [Full Text] [PDF] |
||||
![]() |
M. Cesari, M. T. Sartori, G. M. Patrassi, S. Vettore, and G. P. Rossi Determinants of Plasma Levels of Plasminogen Activator Inhibitor-1 : A Study of Normotensive Twins Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 316 - 320. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |